CLICS/CLICS2022A/commsumm.nsf
PUBLIC
BILL SUMMARY For SB22-173
HOUSE COMMITTEE ON PUBLIC & BEHAVIORAL HEALTH & HUMAN SERVICES
Date May 3, 2022
Location HCR 0112
SB22-173 - Committee Discussion Only
|
|
|
02:47:45 PM |
Representative Bird
and Representative McKean, co-prime bill sponsors, presented Senate Bill
22-173, concerning criteria relating to the operation of telepharmacy outlets.
Under current law, a telepharmacy outlet must be located more than
20 miles from any pharmacy or telepharmacy outlet. The bill removes this
geographic restriction, and requires that a telepharmacy be located in
an area of need, as defined under the bill. The State Board of Pharmacy
is required to adopt rules concerning matters related to telepharmacy outlets.
The bill sponsors responded to questions from the committee.
|
|
02:53:48 PM |
Tom Davis, representing
RxPlus Pharmacies, testified in opposition to the bill.
Ky Davis, representing Harris Pharmacy, testified in opposition to the
bill.
Dr. Maimuna Bruce, representing Telepharm, testified in support of the
bill.
Dr. Jessica Adams, representing Telepharm, testified in support of the
bill.
The panelists responded to questions from the committee.
|
|
03:06:31 PM |
Representative McKean
and Representative Bird explained amendment L.008 (Attachment A). Representative
Bird referenced amendment L.009 (Attachment B). The bill sponsors responded
to questions from the committee.
Mr. Ky Davis responded to additional questions from the committee.
Committee discussion with the bill sponsors ensued.
Dr. Bruce responded to additional questions from the committee.
The bill sponsors responded to additional questions from the committee.
|
|
03:25:34 PM |
The committee came
back to order. Representative Sirota laid over Senate Bill 22-173
until later in the calendar.
|
